Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Change in Cash (2016 - 2025)

Historic Change in Cash for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $97000.0.

  • Nephros' Change in Cash rose 11556.98% to $97000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 22535.8%. This contributed to the annual value of -$547000.0 for FY2024, which is 18127.79% down from last year.
  • Latest data reveals that Nephros reported Change in Cash of $97000.0 as of Q3 2025, which was up 11556.98% from $993000.0 recorded in Q2 2025.
  • Nephros' Change in Cash's 5-year high stood at $1.3 million during Q4 2024, with a 5-year trough of -$1.6 million in Q1 2022.
  • Its 5-year average for Change in Cash is -$162000.0, with a median of -$239000.0 in 2022.
  • Per our database at Business Quant, Nephros' Change in Cash crashed by 170465.12% in 2022 and then skyrocketed by 51365.08% in 2024.
  • Nephros' Change in Cash (Quarter) stood at -$377000.0 in 2021, then grew by 18.83% to -$306000.0 in 2022, then fell by 2.94% to -$315000.0 in 2023, then surged by 513.65% to $1.3 million in 2024, then tumbled by 92.56% to $97000.0 in 2025.
  • Its Change in Cash was $97000.0 in Q3 2025, compared to $993000.0 in Q2 2025 and $321000.0 in Q1 2025.